CRISM' Therapeutics Corp. Stock Analysis CRTX.L

CRISM Therapeutics Corp. is a biotechnology company, which engages in the development of cancer treatment drugs for solid tumors. The firm has developed a drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy. Its lead product, ChemoSeed, is a polymer the size of a grain of rice, administering irinotecan, a generic drug approved to treat brain cancer and can be implanted directly into a tumor or the resection margin following the removal of a tumor, thereby ensuring that effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. The company seeks to use ChemoSeed to treat high grade gliomas, a brain tumor with no satisfactory treatment. The firm also offers formulation and consultancy services. The company provides assistance and services to improve the bioavailability of poorly soluble drugs. The company offers remixers and extruders of various sizes.